Recent studies indicated that KEAP1-NRF2 signaling drives glucose addiction in NSCLC cancer, and cancer cells with KEAP1 inactivation are more vulnerable to glucose deprivation (Figure 2) 18. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.